Aesica is a leading pharmaceutical contract development and manufacturing organisation (CDMO) for both APIs and finished dose forms.
Our full service, end-to-end pharmaceutical development and manufacturing solution comprises capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.
We have state-of-the-art facilities and approximately 1300 colleagues at five development and manufacturing sites in the UK, Germany and Italy, as well as an international office in Shanghai and our Head Office in north London, UK.
Our offering is underpinned by our focus on quality, reliability and service, we are aware that customers want more than a supplier, which is why we work in partnership to provide a flexible, efficient and dependable service.
As part of the Consort Medical group, our offering has expanded to include end-to-end capabilities in the design, industrialisation and manufacture of medical delivery devices, further simplifying the supply chain and increasing control for our customers.
Alembic Pharmaceuticals Limited is one of the leading pharmaceutical companies in India with a consolidated turnover of over US$ 500 Million. Established in 1907, Alembic has expertise in synthetic chemistry, formulation development and solid oral dosage form manufacturing. It has a state-of-the-art R&D facility which focuses on API Process Developments & Process Chemistry, Generic formulation development, Novel Drug Delivery systems, and Bio Equivalence studies. Manufacturing facilities are approved by USFDA, EDQM, German FDA, TGA, KFDA, MHRA, TPD, MCC, COFEPRIS and ANVISA.
Altergon is a leading Pharmaceutical Company in the biotech production of Ultrapure Hyaluronic Acid (Sodium Hyaluronate Bulk) as well as in the production of Patches (Transdermal - Drug in Adhesive - Hydrogel) and Orodispersible Films. The Manufacturing and Purification of Hyaluronate, together with the formulation and manufacturing of Hydrogel medicated plasters are strong Altergon know how.
The company has a high level formulation and development knowhow, and an extensive regulatory experience in US and EU.
Altergon provides a wide range of services for the pharmaceutical industry on a contract basis: Research and Development services with thorough supervision, management and fulfillment of the project, development of topical formulations and drug delivery technologies (pharma and Medical Device).
Apex Drug House is a pharmaceutical company, specialized in development, manufacturing
and marketing of Branded Generics across the globe. Apex offers a wide range of products covering various therapeutic segments . The company excelled in manufacturing Tablets, Capsules, Syrups, Ointments, Dry Powder Injections, Liquid Injections, Ophthalmic solutions and Suppositories. Apex Drug House has also created a niche with its offerings of specialty products like Lozenges, Dermaceuticals, Aerosols, Mosquito Repellents, and Condoms.
Our latest range of products offers complete range of Feminine Wellness Products like Intimate wash, Lubricating Gel, Bust Firming Cream and Foam wash. Apex also manufactures Herbal Supplements and Creams.
We focus on providing quality products and continually invest our time and resources in the quest to achieve higher levels of quality products and earned reputation from our clients. To know more about product offerings, visit us at CphI Worldwide at 90A71
APIRx Pharmaceuticals B.V. is a leading pharmaceutical company dedicated to manufacturing of natural cannabinoid API's (Active Pharmaceutical Ingredients), which are extracted from cannabis plant material and purified to pharma grade. All manufacturing stages are performed under cGMP conditions. The following cannabinoids are in our product portfolio: Tetrahydrocannabinol (THC or Delta-9THC) Cannabidiol (CBD) Cannabigerol (CBG) APIRx also uses its own API's for the development of new Rx and OTC drugs, nutraceuticals, cosmeceuticals and other products.
AQMA.it originates from a pharmaceutical company to promote a new philosophy of care and well-being, thanks to products formulated to the highest standard of quality and efficiency.AQMA.it offers a line of high-quality nutraceuticals and cosmeceuticals all made in Italy, according to the strictest national and international regulations. Our mission at AQMA.it is to care about our clients physical and spiritual health, so every product is subjected to quality control protocols also planned for drugs. AQMA.it has designed a line of nutraceuticals and cosmeceuticals of high scientific profile, all made in Italy and supported by clinical literature.
- ARMOR PHARMA™ lactose monohydrate - Sieved & Milled lactose for sachets, capsules and tablets formulation
- EXCIPRESS™- Granulated and Spray-dried lactose for Direct Compression
- EXCIPURE™ - coarse and fine lactose grades for Dry powder Inhalation
- manufactured under EXCIPACT™ Good Manufacturing Practices, ISO 9001 and ISO 22 000 standards,
- conforming to Ph-Eur, USP-NF, and JP pharmacopoeias
- and exhibiting highest batch-to-batch consistency and intra-batch homogeneity thanks to in-process controls of Particle Size Distribution
- For more information, or to tell us how you would like your lactose:
- [email protected]
The headquarter of AZ GROUP locates in National Health Technology Zone of Zhongshan City, Guang Dong Province, P. R. China. It covers an area of 35,000 square meters, with the convenient transportation of one hour from Hong Kong by ferry. As an international and US FDA cGMP approved company, AZ GROUP is a Sino-US joint venture integrates R&D, manufacturing, marketing and customer services, it has been dedicating to the career of human health since its establishment. The product of AZ GROUP includes Pharmaceutical Products, D-Cal Calcium Supplements, Nutraceuticals and Health Food. It has a variety of international advanced manufacturing & testing equipments and refined production technologies. Strict quality management system and the internationalized specifications have been established to ensure the product quality. Some of our products are US FDA approved and exported to the countries including U.S.A, Europe and Canada etc.
BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing and full technology transfer.
Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time.
Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.
Beximco Pharmaceuticals Ltd. is an international pharma company based in Dhaka, Bangladesh with a presence in more than 50 countries. It is the largest pharma exporter in Bangladesh and won the National Export Trophy (Gold) a record five times. Beximco Pharma's manufacturing facilities are accredited by the regulatory authorities of USA, Australia, Europe, Canada,Taiwan and Brazil, among others. With a broad portfolio of more than 500 products and a focus on specialty niche products, including inhalers, ophthalmics, injectables, oral soluble films, nasal sprays etc., Beximco Pharma is always committed to providing access to affordable medicines manufactured in strict compliance with cGMP.
Established in 1978, Biocon Limited, is India's largest, and Asia's leading, biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide. We develop, manufacture and deliver a rich portfolio of Small Molecules APIs & Formulations and Complex Biologics - both Novels and Biosimilars - including MAbs, rh-insulin& Insulin Analogs. Biocon's robust product portfolio includes the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG and India's first biologic BioMAb-EGFR; for head and neck cancer. It has now successfully developed its second novel biologic Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, being introduced as Alzumab; for psoriasis in India, in 2013.
is a leading Thai pharmaceutical company specialized in the manufacture of a
wide variety of pharmaceutical formulations, including sterile preparations
(small volume liquids and powders), tablets, capsules, powder, liquids,
ointments and creams. Thanks
to our innovations of new generic products and a continuous quality improvement
that allow us to maintain the position of leadership, BIOLAB has become
synonymous with “world class quality”. Our current facilities can support the manufacturing of
niche products, including sterile powder products, lyophilized products and combined hormonal
respect to the contract manufacturing services, we deliver customized services
that respond well to various demands of customers. BIOLAB is
entrusted by renowned Thai and international customers, including Germany,
Japan, Italy, Malaysia, Singapore, Philippines, and Sri Lanka as a contract
manufacturer of their pharmaceutical products. We continue to expand our
presence in global markets and are devoted to satisfying customers with our
quality products and services.
Blanver is a Brazilian company, founded in 1984, which develops, manufactures and commercializes medicines and active pharmaceutical ingredients (APIs). In medicines, we develop and manufacture high quality products in the HIV, hepatitis and osteoporosis segments, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories.Part of our strategy for expanding our pharmaceutical unit is to expand our presence in the international market through partnerships to export our medicines. We are also looking for strategic alliances with international partners of recognized quality, to license and commercialize innovative and established products in segments such as oncology and hematology in Brazil and Latin America.In APIs, focused on HIV, we are increasing our production and development capacity. Blanver develops, produces and incorporates quality and competitive innovative products in its portfolio, always seeking to promote people's health, quality of life and wellbeing. We operate in the state of São Paulo, with corporate headquarters in the Morumbi neighborhood and two production plants – one in the city of Taboão da Serra, where our medicines are manufactured, and the other in Indaiatuba, for production of APIs. Become our partner, contact us for more information. +55 11 3199-8700 | 4138-8200 | [email protected]
Bluepharma is a Portuguese pharmaceutical company resulting from the acquisition of Bayer's former plant in 2001.
Through the entrepreneurship of its promoters, Bluepharma Group currently comprises more than 17 innovative affiliates that cover all stages of the pharmaceutical industry value chain.
Bluepharma's R&D-based strategy allowed to target the most demanding markets of over 40 worldwide territories, representing more than 100 clients and an export rate of 85%.
Bluepharma is FDA approved for the development of solid pharmaceutical forms since 2009, becoming the first Portuguese pharmaceutical company to export to the US market.
Bluepharma offers an integrated approach, from R&D to manufacturing and commercialization of medicines. This is achieved through expertise in formulation, analytical development and scale-up of solid dosage forms as well as through the design of novel platforms (e.g. oral this films and complex injectables) along with dedicated facilities for high potency drugs.This has proven to be determinant in our differatiation and competitiveness.
We aim to create value through innovation.
Croda manufactures specialist excipients for the pharmaceutical industry, which help to improve both the delivery and performance of active pharmaceutical ingredients (APIs) and meet customer needs across multiple delivery forms. We offer high purity Super Refined™ excipients that can optimise the delivery and stability of formulations, whilst maintaining API integrity.
CTP SYSTEM Srl, founded in 1990, is
leader in Italy and one of the most important companies in Europe for the PHARMACEUTICAL, CHEMICAL, HEALTHCARE, COSMETICS, FOOD, and
In 2017, CTP SYSTEM enters AKKA TECHNOLOGIES Group, already a leader in the development of technology services for the Automotive, Railway, Aeronautics, Space & Defense, Oil & Gas sectors.
The integration of CTP SYSTEM within the AKKA Group allows enhancing in synergy each other's competence, also creating a specialized network for the Life Sciences world.
CTP SYSTEM provides management and delivers consulting services to support the customers in each step of the product life cycle, from Research & Development to Process & Plant Engineering, Technology Transfer, Regulatory Support, Process & Plant Qualification,
enabling IT Solutions.
More than 160 high-specialized consultants and the dedicated employee's team of CTP SYSTEM, in addition to over 350 experts of AKKA Group, create a winning NETWORK that grows over time:
- Graduated Engineers
- Pharmaceutical Consultants
- Biologists & Chemists
- Software Specialists
- Validation Consultants
- Project Technicians
The professional staff consists of dynamic people, sharing competence, values and specific know-how, for a better coordination and supervision of all the services provided.
DPT, a Mylan company, is a leading contract development and manufacturing organization, recognized for its excellence in semi-solid and liquid dosage forms. Founded in 1938, DPT provides the best development and manufacturing solutions for our customers. Backed by a team of approximately 1,000 employees in San Antonio, Texas, DPT has unmatched experience, resources and capacity to efficiently serve your pharmaceutical development and manufacturing needs –no matter the scope.
From concept to commercialization, DPT remains committed to exceeding expectations for quality and service. No other company offers a 75-plus year history of stability, superior technical expertise and regulatory merit in semi-solids and liquids.
EBInnov® research laboratory is organized around four areas of expertise:-
1. Innovation- Creation of active ingredients or excipient.
2. Production- Optimization of the production of natural or synthetic substances.
3. Formulation-Design and validation of methods for the formulation and sensory evaluation of pharmaceutical products.
4. Prevention- Evaluation of industrial and environmental risks, product protection
The EBInnov® lab includes all the scientific activities of the faculty and students of the EBI. From research to entrepreneurship, teachers carry out work connected to the problems of our application areas.
EBInnov has facilities dedicated to each of its R & D activities organized in technological platforms and laboratories. Each facility is equipped with all the hardware for performing the techniques necessary for research and applications. They can be used for pedagogical manipulations, but also to development projects or research, or be used by the incubated companies or companies with a need for technology transfer.
is a European-based specialty pharmaceutical company with global reach and a
committed player in the treatment of pain and addiction.
Ethypharm also develops and markets complex generics and essential medicines that help reduce healthcare costs, particularly in the field of emergency care and oncology.
The Company employs 1400 people mainly in Europe, and its drugs are marketed in more than 50 countries.
Our ambition is to become the European leader for the treatment of pain and addiction, and to help patients around the world gain access to high quality, essential and affordable medicines.
FreeThink is a thought leader in the science and technology of stability studies, with some of the most knowledgeable and experienced research scientists in the field. FreeThink scientists have developed a broad fundamental understanding of how temperature, humidity, oxygen, light and time influence the shelf-life of products. As a result, we are adept at helping customers find appropriate, cost-effective solutions to their stability challenges, including physical changes of active forms, formulations, packaging and storage conditions. FreeThink is the scientific expert in stability, committed to developing phase-appropriate stability-indicating methods and applying them to your project. We lead the industry in accelerated processes for modelling product shelf-life, obtaining results in just a few weeks using the ASAPprime® stability software we developed. Our team also excels at longer-term traditional studies, such as those based on the ICH guidelines, and cGMP studies that meet all criteria for regulatory filings. In our state-of-the-art labs, stability studies range from quick evaluations to the most challenging in-depth problem solving.
Chemical Industries Co Ltd is a leading manufacturer of Active Pharmaceutical
Ingredients, Drug Products, Excipients and Natural Astaxanthin. Our specialized
contract manufacturing offers API synthesis, solid dispersion with our spray
drying technology, etc. Additionally, we offer unique excipients for oral
dosage forms, such as Neusilin, Fujicalin. and F-MELT.
Gattefossé is a privately-owned company based in France and present in 60 countries worldwide. We are a leader in functional lipid excipients for improved drug delivery with formulation expertise in oral solubility and bioavailability enhancement, sustained release, taste-masking. We can help re-innovate topical products with skin penetration enhancers and emulsifiers for improved texture and sensorially. We provide bespoke technical and regulatory support to accelerate our customers drug development programmes.
Genovior Biotech Corp. is a vertically integrated contract development and manufacture company, providing following services:
(a) process development of peptide or protein biologics from microbial or human recombinant fermentation processes
(b) formulation development of biological injectables
(c) manufacturing capacities of biologics, lyophilized injectable, and prefilled syringe/cartridge for preclinical, clinical, and commercial uses
Genovior is a dedicated CDMO focusing on providing high quality products at a competitive cost under cGMP and PIC/S for our customers worldwide. Our facilities fully comply with the regulations of FDA, EMA and other agencies, our one-stop services conveniently provide effective and efficient solution and our non-competition policy provides maximum security and protection in IP for our clients.
Gracure is a fully integrated pharmaceutical formulation company with in-house R&D, manufacturing and regulatory compliance capabilities.
We engage in the research, development, manufacturing, sourcing, marketing, and distribution of high-quality pharmaceutical products.
The manufacturing facility have capability to manufacture tablets, capsules, dry syrups, ointments & liquid orals, and is built according to International regulatory guidelines and is approved by EU-GMP, TGA Australia (clearance), UKRAINE GMP and other regulatory agencies like Ethiopia, Uganda, Kenya, Nigeria, Ivory Coast, Ghana and many others.
Grindeks is a vertically integrated pharmaceutical company from Latvia specializing in cardiovascular, CNS and anti-cancer products. Our portfolio of FDFs includes original products and generics. Currently Grindeks produces 24 APIs. Products are exported to 60 markets: of which EU, Japan, Russia and the USA are the main markets.
ICF has been founded in 2002 and it has been the first Brazilian bioequivalence and bioavailability laboratory to get certified by ANVISA (Brazil). It is one of the largest pharmaceutical research centers in Brazil and in Latin America and a notable reference for industries and investors from several countries. ICF's commitment with ethics and innovation assure the credibility and quality of our products.
ICF has already conducted over 700 bioequivalence studies and it takes part in the history of generic drugs in Brazil. We offer one of the biggest hospital infrastructures in the country with a high technology, diversified portfolio and certificate, two hundred bioanalytical methods – including high complexity methods such as hormones and sprays.?
Idifarma is a leading Contract Development and Manufacturing Organization for the pharmaceutical and biotechnology industries. Based in Pamplona (Spain), and with an increasingly international reach, Idifarma provides a full range of services that encompasses: drug formulation, development and validation of analytical methods, quality control and batch release in the EU, Pilot-Scale GMP-compliant manufacturing, ICH stability studies, clinical trial logistics management, regulatory support and commercial GMP manufacturing.
Our state-of-the-art facility features a purpose-built high containment plant for the manufacturing of GMP-compliant batches in oral solid dosage forms, for both conventional and high potency drugs. Our GLP certification allows us to develop products in any pharmaceutical dosage form as well as to carry out physical, chemical and microbiological analysis. Our GMP certification covers the following activities: manufacturing of pilot and commercial batches and as well as clinical batches in oral solid dosage forms (placebo, conventional drugs or high potency drugs), primary and secondary packaging for investigational drugs, importation of drugs and quality control and batch release (for human use drugs as well as investigational drugs).
We work with over 100 clients in more than 10 different countries (mainly in Europe) and during our 10 years
Innophos partners with clients, creating essential ingredients to improve quality of life. We are an international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. Innophos has manufacturing operations across the US, in Canada, Mexico and China.
With over 100 SKUs being supplied globally, Inventia is a rapidly growing FDF development and manufacturing pharmaceutical company, catering to over 80 partners. We offer end to end solutions from product development to supply of the finished product. Our highly skilled teams follow a QbD approach and utilize SAP systems to ensure the highest quality products reach our partners. We cater to over 30 countries from our Manufacturing facility based out of India, which has several regulatory approvals, USFDA, UKMHRA, KFDA, ANVISA, INVIMA, COFEPRIS, GMP SAUMP KFDA, FMHACA, Ghana FDA, JFDA, MCAZ, NAFDAC, PPB, TFDA, UAE MOH Uganda NDA.We believe in building and nurturing long-term relationships – with an aim to be the preferred development and manufacturing partner for any market.
Lamda Laboratories (a Clinigen Company) is an innovative contract development company who focus on providing quality research and development services to the pharmaceutical industry. Known for demanding Generic and Generic-plus developments, Lamda is a one-stop shop for a full registration dossier. Lamda Laboratories offer a service which is tailored to your unique development needs including custom development, dossier licensing and post-approval finished product supply. Investing heavily in infrastructure Lamda delivers on time and on budget for both the development and commercialisation of products. Lamda Laboratories have a highly experienced team that have worked on over a hundred molecules. The successes that Lamda have had to date is a direct result of competence combined with team spirit and a unique dedicated structure.
Lesaffre Human Care was created
in 2007 as a business unit of Lesaffre with the mission to develop and supply
ingredients from yeast and bacteria fermentation to the global human care
markets. With the support of the company's unique know-how as well as more than
160 years of experience in biotechnology and yeast research and manufacturing,
Lesaffre Human Care offers ingredients with scientifically proven efficacy to
the nutritional supplements, pharmaceuticals and functional foods industry.
From nutritional and fortified yeasts to yeasts fractions, probiotic yeasts and bacteria, or pure molecules from fermentation, Lesaffre Human Care has solutions for a wide range of applications such as digestive health, immunity enhancement, women's health, joints and liver health, mood management, vegetarian support, overall wellbeing and beauty.
For further information, visit www://lesaffrehumancare.com
Midas Pharma Polska located in Warsaw offers its complex services to the pharmaceutical industry in Poland and Central & Eastern Europe. Based on our global connections we want to become a partner of first choice in the field of active ingredients, dossiers, international licensing, finished forms and regulatory support.
Milsing is Croatia-based company specialised in the development of healthcare products. Working on the research, development, distribution, marketing and sales, Milsing creates value for its customers and partners worldwide by introducing innovative, premium-quality products, backed by science. Our specialty are innovative dosage formats – chocolate supplements and soft chews. www.chocowise.com
Molteni is an Italian privately-owned pharmaceutical company, founded in 1892 in Florence. It is active in the development and marketing of finished pharmaceutical products in different formulations and strenghts, mainly narcotics for Pain and Addiction treatment. Molteni is continously growing internationally. Outside Italy, the company has direct presence in Poland since 1994, in UK since 2016 and through qualified partners, in many other European and not European countries. Recently we have acquired the rights for EU and other countries including Russia and Iran, for an innovative implant product for treatment of heroin addiction.
Murli Krishna Pharma Pvt is an EU GMP Certified Manufacturer of Pre-Finished Formulations i.e. Pellets using Aqueous Based technology.We have a world class oral solid dosage form manufacturing facility for Pellets, Granules, Micro Pellets and Nano particles of developed countries. Our USP is Total Aqueous based Processes. Our Pellets are Residual Solvents Free and Plant is Solvent free. Accreditation: EU-GMP, WHO-GMP, Jordan FDA
Certifications: EU-GMP, WHO-GMP, and Jordan FDA
USPs of our product:
1. We are 100% EOU zone.
2. Accredited by European Union for GMP Compliances.
3. Total Aqueous based.
4. Dissolution Profile matches to the innovator product
Audited and approved by:
4. Sandoz etc.
Nanjing Pharmacare Co Ltd is a leading supplier of pharmaceutical products, including formulations, APIs, health product and empty gelatin capsules. We have professional team from R&D, Regulatory affairs, BD to logistics. Our core competition includes continuous supply of new generics, GMP pre-audit and CTD dossier on both formulations and APIs.
Natco Pharma Limited based in Hyderabad, India, is a leading manufacturer and exporter of API's and Finished Dosage Forms. Natco has proven technical and operational expertise of over three decades in developing and commercialising APIs and FDFs. Our unwavering commitment to quality; cGMP compliance to deliver affordable drugs with novelty, and improving market access for patients across the world is at the core of everything we do.
Naveh Pharma Ltd, established in 1996, specializes in developing, manufacturing and distributing Pharmaceutical and diverse health care patented products. The Company has developed pharmaceutical products. The proprietary products are being sold in Pharmacies and are mainly targeted as OTC Home Care Treatments under the slogan "Common Problems - Smart Solutions". Naveh Pharma exports its products to more than 30 countries, and wishes to expand its global export, thus, seeking for distributors . Naveh Pharma is ISO 9001: 2008, ISO 13485 : 2003, CAN/CSA ISO 13485:2003 and CE certified company.
Established in 1982, Neon has earned reputation as one of the leading pharmaceutical companies in India. Over the last three decades, Neon has successfully explored new horizons in the industry with core initiatives to lead the company through innovation and research. Furthermore, Neon has established their global presence by supplying high quality branded generic formulations. We are leaders in Anesthesia segment with the product basket of 40 plus molecules. We specialized in various Lidocaine & Bupivacaine dosage forms. Our key areas of business are Formulation, API and Medical Devices. After attaining leadership position in Domestic Market, Neon now aims at achieving substantial position in International markets. Joint venture and tech transfer has given a great boost to the growth of the company.
Aspiring to continuously add value in healthcare industry, we endeavor to lead the company with total integrity and highest ethical standards, by predominantly emphasizing on the wellbeing of our teammates (Stakeholders) and the communities we serve.
Our Mission is to become a global leader in the Healthcare industry by offering the world class quality products and consistent services. We constantly strive to expand our manufacturing facility by adopting the latest technology and investing in R&D, to assure quality products at affordable prices to our customers and business partners.
We have four manufacturing plants at different locations with fully equipped state-of-the-art technology and modern infrastructure. We always maintain current GMP standard prescribed by W.H.O. We have a team of highly educated and expert professionals with long-term experience in the pharmaceutical industry. We are capable of supporting small as well as big volume batch sizes. For Lyophilized products, we have an ice condensing capacity of 10kgs, 100kgs & 300kgs. Our team of veteran professionals works with complete dedication and enthusiasm in order to deliver our customers best products and services across the globe.
We have a field force of over 1000 medical representatives all over India that strengthen our marketing activities and cover each and every hospital in India. We take lot of efforts in training and developing our Marketing team so as it becomes integral part of the company.
We have following divisions dedicated to specific therapies ANAESTHETIA DIVISION, CRITICARE DIVISION,MAXNEON DIVISION , OMACRAE DIVISION , MAXICARE DIVISION. Six of our brands are leading brands as per ORG-MARG. We have over 28 distributors and we have more than 500 products being regularly sold in India.
With an aim to grow in the international market, we have spread our business in several countries of ASIA, Africa, Latin America and CIS, with further expansion plans in regulated market. Our regulatory department is efficient & has registered more than 300 products in 60 different countries. We also strive to make tie-up with international companies in order to build a global network through our proficiency, long-term experience, implementing new technology as well as the hard work of research team and business associates.
Our core business is development and production of Parenteral Formulations i.e. Dry powders, Liquid Injections, Pre-Filled Syringes and Lyophilized injections. We have persistently expanded our spectrum of business by developing, licensing, manufacturing and marketing many key products. We also specialize in developing formulations and APIs (Active Pharma Ingredients) on contract basis for our reliable partners with complete confidentiality and exclusive agreements.
We cater to following therapeutic segment
• Critical care
• Medical Device
• Other Healthcare products
Our R&D facility
We have fully equipped R&D facility which becomes the heart of our company. For more than three decades, with the help of our R&D experts, we have achieved many milestones and successfully launched 7 brands/molecules 1st time in India like
Myo-Pyrolate (Neostigmin+Glycopyrrolate) Cloneon (Clonidine) Potphos (Potasium Phosphate) Nelcium ( Calcium Chloride) Sodac 8.4% (Sodium Bicarbonate) R&D has helped us to earn a reputation in the market as a most trusted name for supplying the best quality healthcare products.
Novelty Pharma Galenical Development and Documentation is a Swiss healthcare company focused on innovative pharmaceutical and nutraceutical products that improve quality of life. We offer contract services in the areas of development, manufacturing, registration, outsourcing of active ingredients and finished products - providing novel solutions to our business partners worldwide. Novelty Pharma has more than 15 years of experience in effervescent formulations. CTD dossiers and MA for OTC and prescription drugs are available for worldwide licensing. We strive at bringing Rapid, High and Complete Absorption through novel delivery methods to the consumer for a enhanced lifestyle.
We are a professionally managed company serving pharmaceutical industry through an extensive range of pharmaceutical formulations, active ingredients (API's) and excipients. Our team of specialists can accommodate all our clients' requirements.
As a company dealing with Pharmaceutical products, we work in strict conformity with Swissmedic (Swiss Health Authorities) guidelines.
"Optimus is a unique API, Advance Intermediates and Formulations/pellets manufacturer. Optimus is approved and admired by many regulatory authorities and customers globally. We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry."
Optimus is a Hyderabad, India based company, we are approved by US FDA, EU GMP, COFEPRIS MEXICO, KFDA, WHO GENEVA and ISO. We have our business footprint in most of the global regions like LATAM, US, EU, MENA, CIS/RUSSIA, ASIA & INDIA.
PharOS is a privately owned company located in Greece and is considered among the fastest growing Pharmaceutical Development companies in Europe. PharOS is providing a diversified range of own and co-developed pharmaceutical products, including Generics, Fixed Dose Combinations, OTCs and other value added products. With a global portfolio of more than 67 products (27 already launched) and over 6,500 Marketing Authorizations worldwide, we aim to improve the quality of life of patients in more than 85 countries. In addition, PharOS is providing value added services in the field of Product Development, Regulatory Affairs and Business Development Consulting.
Rafarm is a Greek pharmaceutical company with extended experience in the development, manufacturing, out-licensing and marketing of pharmaceutical products. We grow together; Planning with care for the future by continuously investing in our GMP facility and strong team of qualified professionals, in order to deliver to you, a wide range of products and services fully customized to suit your needs. Specialized in ophthalmic and sterile products, we also offer solids, semisolids, liquids and creams always implementing our philosophy “Health care. Human care.”. Today with your support we celebrate 45 years of Rafarm and add FDA approval of our sterile line.
Founded in 1929, Reig Jofre is #5 Spanish pharmaceutical company by turnover that trades on the Spanish stock exchange under the ticker RJF. It is devoted to the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements, as well as on specialized contract development and manufacturing. The company directs its activity in two business units: • technological specialization area (49.7% of total sales) in the development and manufacture of antibiotics derived from penicillin and sterile injectable products, which made possible to grow internationally and distribute or license Reig Jofre products in more than 65 countries on five continents. • therapeutic areas and health care (50.3% of sales) focused on the research, development, manufacture and marketing of our own developments in dermatology and gynecology, mainly, and in the development of OTCs products in the field of ENT and topical disinfectants. This area also includes the line of nutritional supplements, marketed under Forté Pharma brand, mainly in France, Belgium, Spain and Portugal. Reig Jofre has about 1,000 employees, 4 development and manufacturing centers in Europe (Spain: 1 in Barcelona &, 2 in Toledo; and 1 in Sweden), direct sales in 7 countries and over 130 commercial partners in more than 65 countries worldwide.
Sai Life Sciences Ltd is a strategic contract development and manufacturing service provider, with a broad technology platform tailored to accelerate Discovery, Development and Commercial Supply of RSM's, intermediates & NCE's of pharma and biotech companies. Sai's core competence is the development and scale-up of complex processes (long syntheses) and volumes from kgs up to 50mt/yr. Sai has focused on building expert capabilities in chemistry: synthetic chemistry, medicinal chemistry, process development, scale-up chemistry, analytical development and cGMP (FDA & PMDA approved) manufacturing. It has also expanded to provide high-quality formulation development services as well as DMPK, Toxicology and Biology Discovery services.
Shenzhen Mellow Hope Pharm Industrial Co Ltd, specializing in exporting biological products, has grown to be one of the biggest exporters of vaccines and bio-pharmaceuticals in China after ten-year of unremitting efforts.
Mellow Hope cooperates with many well-known biological institutes and companies in the Research & Development of new products and introductions of new technologies, as well as conducts registrations, carries out clinical trials, promotes and markets products around the world. In order to meet different market demands and standards, Mellow Hope has created a unique and effective operating model to supply the global customers with a series of high-quality and innovative biological products. Mellow Hope is on its way to be one of the world-famous biological product operators.
While promoting its biological products vigorously in the international market, Mellow Hope is also trying its best to bring high-end biological products and technologies to the Chinese market. Serum Institute of India Ltd., which is the largest MMR vaccine manufacturer in the world, has already appointed Mellow Hope as its exclusive agent in China for registration and sales of MMR vaccine.
SOFAR SPA is an Italian pharmaceutical company producing branded pharmaceuticals, medical devices and dietary supplements of the highest quality, mainly in the fields of Gastroenterology, Gynecology, Urology, Dermatology and Pediatrics. SOFAR SPA has more than 45 years of experience in the Pharmaceutical and Nutritional field. The outstanding performance of the company is an example of how the experience gained can lead to innovative solutions that improve the quality of human life. Expertise, Flexibility and Innovation are the values guiding us and allowing to design, develop, produce and distribute the innovative products for the health and the well-being of the people.
Synokem Pharmaceuticals Ltd started its operations in the 1982, with a vision of empowering life with quality medicines on competitive prices and timely availability to each segment of population.
Started operations with own ethical marketing and in year 2005 management took a strategic decision to establish own manufacturing site. Synokem Pharma came up with its own WHO-GMP plant in year 2006.
With all best efforts from management and quality staff, soon the SYNOKEM PHARMA became a renowned name among the top companies such as ZYDUS, MANKIND, ABBOTT, CIPLA, SUNPHARMA and many more for their contract manufacturing requirements.
All such companies are with us since the inception of SYNOKEM PHARMA and the relations are getting stronger.
• Strong R&D, QC (GLP certified) and QA team.
• Launching of new molecules for contract manufacturing parties and for self-export market
• Focused QC /QA team which work on molecules those are going to off patent in next 5 years.
• Products in pipe line (under development), more than 150
• First company in India to launch AZILSARTAN
• Only company in world to have Progesteron tab SR technique
• Capable to work on turnkey projects / tech transfers
• Strong regulatory teams for domestic and export requirements.
Turnover / Infrastructure / Technology
At Synokem, management understands the value of ever-changing technology, and investing heavily to keep itself abreast with the latest changes in pharma industry. With latest independent lab that is equipped with all modern QC apparatus, Synokem is ready to perform all related drug test in house only.
In 2015, to meet the product demand of clients on given time, management has invested into new manufacturing plant, which is designed as per US FDA norms.
With the support of all prominent clients, SYNOKEM has touched the mark of USD 90 mn for last FY, i.e. INR 500 + Cr.
Synokem also have plans to come up with different therapeutic segment and the concerned teams are working on same.
Synokem Pharmaceuticals works on 4 business verticals and expanded well in all with dedicated departments / teams.
1. Contract Manufacturing
2. Ethical division (More than 150 medical reps)
3. Institutional sales (participating all big hospital tenders / state tenders)
4. Export Division
The parallel diversifications made by synokem management in strategic way and on right intervals. Initial focus was on contract mfg and institutional sale after plant came into existence and launched its own ethical team thereafter. The Ethical team has now coverage of East / North and West part of India.
Overseas Venture / future aspects:-
Synokem Management has clear vision to excel in overseas markets and for same they launched export division with separate regularly department in year 2014.
In recent past, Synokem has made its marks in various overseas markets with accreditations from different FDAs.
Synokem: - International Approvals / Presence / Export status
SEA & FDAs Cambodia Philippines Myanmar
MOH PFDA Registered
SAARC Srilanka Bhutan Nepal Afghanistan
CDDA MOH DDA Active
Latam Peru Ecudaor Chile Venezuela
Active Active Active Only Tender
CIS Uzbekistan Armenia Serbia Gerogia Krgyzstan
Active Bulk supply Active Active In process
Others Yemen Qatar Oman
Audit filed Under Registration Filing in process
Kenya Uganda Ghana Nigeria Ivory Coast
Africa & FDA`s PPB NDA FDA NAFDAC DPM
Zambia Tanzania Ethiopia Botswana DRC
Registered Audit Filed Audit Filed Under Registration Active
Synokem Agenda for future:-
The future plan for Synokem is to get its facility audited successfully from,
For the same, the QA / QC teams are working on documentary part and all together are gearing up for it with a target to achieve same by 2020.
WACKER is a globally active chemical company with 13,811 employees and annual sales of around 4.92 billion (as of December 2017). WACKER is represented by subsidiaries and sales offices in 31 countries in the Americas, Asia, Australia and Europe, and operates 23 production sites worldwide. WACKER offers you a unique product portfolio comprising complex organic intermediates, organosilanes, chiral molecules (building blocks), cyclodextrins and cysteines, as well as various chemical starting materials, silicones, fine chemicals, PVAc solid resins and colloidal anhydrous silica. WACKER's colloidal anhydrous silica HDK® has a proven track record as an excipient. It optimises the flow behaviour of powders and is used as a thickener for liquid formulations.
Wyjolab SA is an advanced GMP-compliant pharmaceutical laboratory that
works with leading healthcare companies to develop and manufacture
pharmaceuticals and nutritional products.
Wyjolab's state-of-the-art facilities offer customers a wide range of dosage forms (liquids, semi-liquids, powders, extruded polymer, etc.) and many packaging solutions including stick-packs. A strict quality control process guarantees quality from raw materials to finished product. Wyjolab is equipped to conduct constant tests throughout the development process or in ongoing test protocols.
With nearly 30 years of experience in product development, Wyjolab also has deep expertise in galenic and analytical services, as well as suspension and oral applicator technologies.
XL Laboratories is an EU GMP, PIC/S, SAUMP Ukraine, FMHACA Ethiopia, FDA Philippines, WHO-GMP, GLP and HALAL etc. accredited pharmaceutical manufacturing company. Our facilities are audited by MOH / FDA of many countries and client audit teams. XL houses an R&D center (approved by DSIR, Govt. of India) catering to development and validation of analytical procedures & formulation for own use and on contract basis. XL has 2 pharmaceutical manufacturing facilities:- 1.Plant I at Bhiwadi (Rajasthan) for the manufacturing of Tablets, Hard Gelatin Capsules, Oral Liquids & Powder/Granules in Sachet. 2.Plant II at Neemrana (Rajasthan) for the manufacturing Soft Gelatin Capsules. XL is present in over 30 countries with more than 400 product registrations encompassing over 45 therapeutic segments.The manufacturing processes employ latest technological equipment with end to end automation to minimize manual handling of materials and online instruments to assess critical parameters and mitigate risk during manufacturing. We are offering contract manufacturing & development (analytical & formulation) services for Tablets, Hard & Soft Gelatin Capsules, Oral Liquids and Powder/Granules in Sachet, dossier development and validation batches. In house Regulatory Department at XL which works for international filings and understands the needs of regulatory documentation of each country thereby ensuring precise and accurate document submission. We are offering manufacturing & contract development (analytical & formulation) services for Tablets, Hard & Soft Gelatin Capsules, Oral Liquids and Powder/Granules in Sachet, dossier development, validation batches and out licensing. In house Regulatory Department at XL which works for international filings and understands the needs of regulatory documentation of each country thereby ensuring precise and accurate document submission swiftly.